We missed writing about Affymax, Inc. (OTCMKTS:AFFY) as we haven’t covered them for about a week now. Today, however, we decided that the fact that they dropped below $1 again deserves some attention even...
Read through the press releases and have a look through the financial reports and you will probably think that things are going along nicely for Applied DNA Sciences Inc (OTCBB:APDN) and their shareholders. Have...
As is the case with most of the companies that we review on these pages, Advanced Cell Technology, Inc. (OTCBB:ACTC)’s share price often moves when some positive news comes out. A classic case in...
In the 21st century, investing in the future may mean a financial action or a biological one, namely saving up stem cells to serve the future health of children. The promise of stem cells...
The biotech boom among small cap stocks attracts new tickers which awaken from long-term valleys. The trend called forth Rxi Pharmaceuticals Corporation (OTC:RXII) and the stock managed to climb near its all-time peaks. The...
The new year seems to be good for pharmaceutical science, as many developers of new drugs and therapies started a steep climb in price, attracting healthy trading volume. Another ticker to share this fate...
Penny stock circles see a lot of promise in the field of biotechnologies, and news in this area help lift tickers dramatically. Gererex Biotechnologies, Inc. (OTC:GNBT) spiked by 59.5% on Wednesday as the company...
Another stem cell wonder has appeared among the most actively traded small caps for Tuesday. International Stem Cell Corp. (OTC:ISCO) added more than 27% to its stock price, getting into another upward swing on...
In Friday trading Advanced Cell Technology, Inc. (OTC:ACTC) made a big move up the charts, reaching its previous 3-month high of $0.079 per share. The move was significant but was it also warranted? ACTC...
What is more suitable for a new year than a medical therapy promising total renewal, this time with stem cell technology? Our old acquaintance Advanced Cell Technology Inc. (OTC:ACTC) makes the rounds again, picking...